Century Sage Scientific Holdings Limited
HKEX:1450.HK
1.05 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,074.335 | 425.606 | 202.788 | 153.306 | 191.03 | 298.704 | 462.78 | 662.888 | 623.432 | 748.535 | 628.758 |
| Cost of Revenue
| 507.425 | 235.81 | 142.457 | 97.455 | 142.443 | 237.579 | 335.713 | 467.616 | 440.488 | 517.583 | 435.198 |
| Gross Profit
| 566.91 | 189.796 | 60.331 | 55.851 | 48.587 | 61.125 | 127.067 | 195.272 | 182.944 | 230.952 | 193.56 |
| Gross Profit Ratio
| 0.528 | 0.446 | 0.298 | 0.364 | 0.254 | 0.205 | 0.275 | 0.295 | 0.293 | 0.309 | 0.308 |
| Reseach & Development Expenses
| 0 | 0.027 | 0.175 | 9.818 | 4.454 | 3.751 | 3.05 | 1.751 | 0.339 | 0.02 | 5.275 |
| General & Administrative Expenses
| 173.646 | 107.847 | 76.172 | 79.559 | 108.996 | 96.737 | 90.03 | 93.103 | 85.847 | 78.051 | 62.928 |
| Selling & Marketing Expenses
| 261.678 | 70.86 | 10.929 | 10.922 | 19.925 | 25.465 | 29.026 | 35.477 | 34.685 | 32.567 | 33.356 |
| SG&A
| 435.324 | 178.799 | 93.225 | 112.248 | 130.977 | 122.202 | 119.056 | 128.58 | 120.532 | 110.618 | 96.284 |
| Other Expenses
| -0.174 | 0.025 | 0.329 | 0.198 | 2.357 | 0.713 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 431.084 | 181.668 | 118.058 | 144.029 | 123.553 | 76.68 | 275.806 | 125.496 | 120.344 | 115.5 | 95.923 |
| Operating Income
| 145.781 | 13.785 | -27.454 | -52.087 | -78.302 | -55.635 | 16.051 | 70.286 | 66.526 | 120.936 | 97.508 |
| Operating Income Ratio
| 0.136 | 0.032 | -0.135 | -0.34 | -0.41 | -0.186 | 0.035 | 0.106 | 0.107 | 0.162 | 0.155 |
| Total Other Income Expenses Net
| 12.863 | -19.841 | -44.78 | -47.571 | -13.237 | 24.989 | -182.336 | -8.858 | -9.349 | -8.796 | -3.362 |
| Income Before Tax
| 139.519 | -6.056 | -72.234 | -99.658 | -91.539 | -30.646 | -166.285 | 61.428 | 57.177 | 112.14 | 94.146 |
| Income Before Tax Ratio
| 0.13 | -0.014 | -0.356 | -0.65 | -0.479 | -0.103 | -0.359 | 0.093 | 0.092 | 0.15 | 0.15 |
| Income Tax Expense
| 25.548 | 10.335 | 3.51 | 1.701 | 2.895 | 8.156 | 1.39 | 8.881 | 7.09 | 15.087 | 16.391 |
| Net Income
| 119.462 | -9.207 | -61.615 | -97.531 | -84.325 | -38.606 | -170.24 | 51.396 | 50.087 | 97.053 | 77.755 |
| Net Income Ratio
| 0.111 | -0.022 | -0.304 | -0.636 | -0.441 | -0.129 | -0.368 | 0.078 | 0.08 | 0.13 | 0.124 |
| EPS
| 0.091 | -0.008 | -0.058 | -0.094 | -0.082 | -0.038 | -0.17 | 0.051 | 0.05 | 0.11 | 0.1 |
| EPS Diluted
| 0.087 | -0.008 | -0.058 | -0.094 | -0.082 | -0.038 | -0.17 | 0.051 | 0.05 | 0.11 | 0.1 |
| EBITDA
| 174.173 | 18.009 | -22.515 | -44.957 | -70.639 | -45.144 | 25.432 | 82.301 | 77.539 | 130.524 | 105.843 |
| EBITDA Ratio
| 0.162 | 0.042 | -0.111 | -0.293 | -0.37 | -0.151 | 0.055 | 0.124 | 0.124 | 0.174 | 0.168 |